examines current advances in the study of the role of miRNAs in
cancer, including prostate
cancer. Issues
Beilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) further makes them suitable as
cancer biomarkers. Studies involving human tumors have verified differences
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patient. Bioinformatics analysis was conducted and the most significant mutations in prostate
cancerBackground/aims: Colon
cancer remains a life-threating disease with increasing morbidity
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) -specific macrophages and from newly recruited monocytes. TAMs’ variability strongly depends on
cancer type, stage